Cecilia A C Prinsen
Overview
Explore the profile of Cecilia A C Prinsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tobey T, Ortega-Loayza A, Choe S, Haddadin O, Bardazzi F, Croitoru D, et al.
Arch Dermatol Res
. 2025 Feb;
317(1):449.
PMID: 39979653
Pyoderma gangrenosum (PG) is a debilitating inflammatory skin condition characterized by painful, necrotic ulcers, significantly impairing patient quality of life. The variability in clinical outcomes and the lack of standardized...
2.
Korte E, Pasmooij A, Bolling M, Hickey S, Hussain S, Kiritsi D, et al.
Br J Dermatol
. 2024 Jun;
191(3):463-465.
PMID: 38865426
No abstract available.
3.
Braaksma C, Wolterbeek N, Veen R, Prinsen C, Ostelo R
Value Health
. 2022 Aug;
25(11):1894-1901.
PMID: 36031481
Objectives: A frequently used patient-reported outcome measure for assessing physical functioning in patients with hip problems is the 5-item Hip Disability and Osteoarthritis Outcome Score-Physical Function Shortform (HOOS-PS). Nevertheless, its...
4.
Terwee C, Elders P, Langendoen-Gort M, Elsman E, Prinsen C, van der Heijden A, et al.
Curr Diab Rep
. 2022 Jul;
22(9):405-421.
PMID: 35819705
Purpose Of Review: We aimed to systematically evaluate the content validity of patient-reported outcome measures (PROMs) specifically developed to measure (aspects of) health-related quality of life (HRQOL) in people with...
5.
Langendoen-Gort M, Groeneveld L, Prinsen C, Beulens J, Elders P, Halperin I, et al.
Rev Endocr Metab Disord
. 2022 Jul;
23(5):931-977.
PMID: 35779199
Patient-Reported Outcome Measures (PROMs) are important tools to assess outcomes relevant to patients, with Health-Related Quality Of Life (HRQOL) as an important construct to be measured. Many different HRQOL PROMs...
6.
Gorst S, Prinsen C, Salcher-Konrad M, Matvienko-Sikar K, Williamson P, Terwee C
J Clin Epidemiol
. 2020 May;
125:64-75.
PMID: 32470621
Objectives: Once a core outcome set (COS) has been defined, it is important to achieve consensus on how these outcomes should be measured. The aims of this systematic review were...
7.
Leshem Y, Chalmers J, Apfelbacher C, Furue M, Gerbens L, Prinsen C, et al.
J Am Acad Dermatol
. 2020 Jan;
82(5):1181-1186.
PMID: 31926221
Background: Measuring patient-centered outcomes in clinical practice is valuable for monitoring patients and advancing real-world research. A new initiative from the Harmonising Outcome Measures for Eczema (HOME) group aims to...
8.
Horbach S, Rongen A, Elbers R, van der Horst C, Prinsen C, Spuls P
Qual Life Res
. 2019 Sep;
29(1):1-17.
PMID: 31549367
Purpose: The Outcome measures for vascular malformation (OVAMA) group reached consensus on the core outcome domains for the core outcome set (COS) for peripheral vascular malformations (venous, lymphatic and arteriovenous...
9.
Prinsen C, Terwee C
Public Health
. 2019 Apr;
170:70-77.
PMID: 30974374
Objectives: Huber et al. introduced a new concept 'positive health', defined as 'the ability to adapt and self-manage in the face of social, physical and emotional challenges' and suggested a...
10.
Prinsen C, Spuls P, Kottner J, Thomas K, Apfelbacher C, Chalmers J, et al.
J Am Acad Dermatol
. 2019 Mar;
81(1):297-305.
PMID: 30878565
The development of core outcome sets (COSs; ie, a minimum set of core outcomes that should be measured and reported in all trials or in clinical practice for a specific...